Nelson Fontanez

683 total citations
5 papers, 369 citations indexed

About

Nelson Fontanez is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nelson Fontanez has authored 5 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nelson Fontanez's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipid metabolism and disorders (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Nelson Fontanez is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipid metabolism and disorders (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Nelson Fontanez collaborates with scholars based in United States, Canada and France. Nelson Fontanez's co-authors include Henry N. Ginsberg, Rajasekhar Ramakrishnan, Steve Holleran, Colleen Ngai, André Bensadoun, Jeffrey S. Cohn, Daniel Donovan, Kazunori Nagashima, Jamila Fruchart‐Najib and Michael Lefevre and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Clinical Nutrition and Science Translational Medicine.

In The Last Decade

Nelson Fontanez

5 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nelson Fontanez United States	4	211	157	119	88	88	5	369
Björn Wahlstrand Sweden	11	104 0.5×	151 1.0×	89 0.7×	122 1.4×	41 0.5×	13	404
H.-U. Häring Germany	13	182 0.9×	154 1.0×	101 0.8×	51 0.6×	61 0.7×	29	493
Niina Mero Finland	7	338 1.6×	82 0.5×	145 1.2×	185 2.1×	125 1.4×	7	464
Bruno Vergès France	9	261 1.2×	107 0.7×	174 1.5×	62 0.7×	209 2.4×	14	466
L. Perségol France	10	240 1.1×	113 0.7×	190 1.6×	77 0.9×	54 0.6×	14	409
Saleem Ullah Shahid Pakistan	13	88 0.4×	149 0.9×	89 0.7×	67 0.8×	91 1.0×	26	404
Patty W. Siri United States	7	211 1.0×	161 1.0×	126 1.1×	72 0.8×	154 1.8×	7	508
Guiyun Ruan China	6	94 0.4×	83 0.5×	96 0.8×	85 1.0×	71 0.8×	6	295
Ben A. Kappel Germany	12	88 0.4×	278 1.8×	77 0.6×	73 0.8×	61 0.7×	20	441
Toshiki Hozumi Japan	10	157 0.7×	117 0.7×	88 0.7×	48 0.5×	47 0.5×	19	337

Countries citing papers authored by Nelson Fontanez

Since Specialization

Citations

This map shows the geographic impact of Nelson Fontanez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelson Fontanez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelson Fontanez more than expected).

Fields of papers citing papers by Nelson Fontanez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelson Fontanez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelson Fontanez. The network helps show where Nelson Fontanez may publish in the future.

Co-authorship network of co-authors of Nelson Fontanez

This figure shows the co-authorship network connecting the top 25 collaborators of Nelson Fontanez. A scholar is included among the top collaborators of Nelson Fontanez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nelson Fontanez. Nelson Fontanez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Reyes‐Soffer, Gissette, Byoung C. Moon, Antonio Hernández‐Ono, et al.. (2016). Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans. Science Translational Medicine. 8(323). 323ra12–323ra12. 22 indexed citations

2.

Holleran, Stephen, S. Ramakrishnan, Wahida Karmally, et al.. (2014). Treatment with mipomersen reduces levels of apoB-containing lipoproteins by increasing fractional removal of VLDL and LDL-apoB without reducing vldl-apob secretion. Atherosclerosis. 235(2). e60–e60. 1 indexed citations

3.

Nagashima, Kazunori, Daniel Donovan, Colleen Ngai, et al.. (2005). Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. Journal of Clinical Investigation. 115(5). 1323–1332. 153 indexed citations

4.

Nagashima, Kazunori, Daniel Donovan, Colleen Ngai, et al.. (2005). Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. Journal of Clinical Investigation. 115(5). 1323–1332. 139 indexed citations

5.

Berglund, Lars, Elizabeth Oliver, Nelson Fontanez, et al.. (1999). HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. American Journal of Clinical Nutrition. 70(6). 992–1000. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact